United States
US 12,697,324 B2
Use of compound as CYP2E1 inhibitor
US 12,697,324 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-04. Applicant: Suzhou Lingxi Biotechnology Co., Ltd. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- Suzhou Lingxi Biotechnology Co., Ltd.
- Inventors
- Hailing QIAO; Haiwei XU; Yan FANG; Na GAO; Qiang WEN; Shufeng LI
- Publication date
- 2026-08-04
- Filing date
- 2023-03-01
- Document type
- B2 Granted patent
- Also written as
- US 12,697,324 B2 · US12697324 · 12697324
Abstract
A use of a compound as a CYP2E1 inhibitor includes: using a compound shown in formula (I) or a salt thereof as an inhibitor to inhibit CYP2E1, where the compound or the salt thereof targets and binds to CYP2E1. The inhibitor can be used for the prevention and treatment of a tumor including liver cancer, glioma, ovarian cancer, lung cancer, bladder cancer, and gallbladder cancer.…
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free